Seizert Capital Partners’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-161,998	Closed	-$476K	–	262
2018 Q2	$476K	Hold	161,998	–	–	0.02%	161
2018 Q1	$476K	Sell	161,998 -1,013,781	-86%	-$2.77M	0.02%	161
2017 Q4	$3.22M	Buy	1,175,779 +24,892	+2%	+$76.5K	0.12%	83
2017 Q3	$3.9M	Sell	1,150,887 -112,073	-9%	-$312K	0.14%	75
2017 Q2	$3.12M	Buy	1,262,960 +70,874	+6%	+$163K	0.11%	90
2017 Q1	$2.71M	Buy	+1,192,086	New	+$2.64M	0.1%	100
2015 Q3	–	Sell	-528,809	Closed	-$3.4M	–	215
2015 Q2	$3.4M	Sell	528,809 -28,235	-5%	-$189K	0.09%	123
2015 Q1	$3.92M	Sell	557,044 -36,570	-6%	-$265K	0.1%	119
2014 Q4	$4.58M	Sell	593,614 -83,419	-12%	-$660K	0.1%	112
2014 Q3	$5.06M	Buy	677,033 +60,878	+10%	+$565K	0.1%	105
2014 Q2	$5.96M	Buy	616,155 +398,335	+183%	+$3.55M	0.12%	88
2014 Q1	$1.81M	Buy	217,820 +51,370	+31%	+$440K	0.04%	95
2013 Q4	$1.41M	Buy	+166,450	New	+$1.4M	0.03%	108